Net delta exposure for Amphastar Pharmaceuticals Inc (AMPH) options was $467.04K per 1% move at the Nov 20, 2026 close. It has been positive on 20 of the last 20 trading days. Four weeks earlier, on Oct 23, 2026, it was $388.58K.
Upgrade to unlock Call Wall, Put Wall, and multiple expiration dates.
Delta Exposure by Strike
Showing results for AMPH, 2026-12-18(m), calls & puts
Delta Exposure Stats
Showing results for AMPH, 2026-12-18(m), calls & puts
| Net DEX ($ per 1% move) | $0 |
|---|---|
| Call DEX ($ per 1% move) | $0 |
| Put DEX ($ per 1% move) | $0 |
| Call Wall | |
| Put Wall |
Net Delta Exposure by Expiration
Showing results for AMPH, 2026-12-18(m), calls & puts. View all expiries
| Expiration | Net DEX | Call DEX | Put DEX | Call Wall | Put Wall |
|---|---|---|---|---|---|
| Dec 18, 2026 26 DTE monthly | $0 | $0 | $0 |
AMPH Delta Exposure FAQ
What is delta exposure (DEX)?
Delta exposure estimates the dollar value of shares option dealers hold or owe as a hedge, per 1% move in the underlying.
Is AMPH delta exposure positive or negative?
Amphastar Pharmaceuticals net delta exposure was positive on Nov 20, 2026, at $467.04K. It has been positive on 20 of the last 20 trading days.
How has AMPH delta exposure changed recently?
Amphastar Pharmaceuticals net delta exposure went from $388.58K on Oct 23, 2026 to $467.04K on Nov 20, 2026. See the AMPH delta exposure history for a longer view.
What is Amphastar Pharmaceuticals Inc?
Amphastar Pharmaceuticals Inc is a bio-pharmaceutical company focusing on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (or insulin API products.